🌏 Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) Annual Scientific Meeting 2025 (5–7 February 2025)

Wednesday February 5th, 2025 (Day 1)
Plenary Session 1: Cellular Immunotherapy I

• Role of HSCT vs CAR T cells in Hematologic Malignancy 
  Assoc. Prof. Kitsada Wudhikarn, Division of Hematology, Faculty of Medicine, Chulalongkorn University, Thailand

• Challenges in delivering cellular therapies for transplant recipients and cancer patients
  Prof.Rajiv Khanna, Co-Director, Queensland Immunology Research Centre; Distinguished Scientist, Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Australia

• mRNA-based T cell engineering for treatment of virus-related cancer and virus infection
  Prof.Antonio Bertoletti, Duke-NUS Graduate Medical School, Singapor

Plenary Session 2: Cellular Immunotherapy II

• Immunotherapy II Clinical Application of Mesenchymal Stem Cells: Current Trends and Future Directions
  Prof.Jacques Galipeau, Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health, University of Wisconsin in Madison, USA

• T cell receptors and MHC diversity in risk, prognosis, and therapy for gliomas
  Asst. Prof.Gary Kohanbash, Director, PNIO Laboratory, Faculty of the Department of Neurological Surgery at UPMC Children’s Hospital of Pittsburgh, USA

• Novel pans solid tumor CAR T cells and first in human trial in DIPG
  Assoc. Prof.Supannikar Tawinwung, Cellular Immunotherapy Research Unit, Chulalongkorn University; Facility Director, Cell and Gene Therapy Manufacturing Center, King Chulalongkorn Memorial Hospital, Thailand

🌏 Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) Annual Scientific Meeting 2025 (5–7 February 2025)

Thursday February 6th, 2025 (Day 2)
Plenary Session 3: Haematopoietic Stem Cell Transplantation

• HSCT: An update
  Dr.Dianne De Santis, Senior Medical Scientist,Department of Clinical Immunology, PathWest, Royal Perth Hospital, Australia

• Saving Lives Across Borders: The Asia-Pacific Unrelated Stem Cell Donor Registry Experience
  Pawinee Kupatawintu, National Blood Center, the Thai Red Cross Society, Thailand

• Saving Lives Across Borders: The Asia-Pacific Unrelated Stem Cell Donor Registry Experience
  Prof.Ram Mohan Jaiswal, Mahatma Gandhi Medical College & Hospital, India

• Saving Lives Across Borders: The Asia-Pacific Unrelated Stem Cell Donor Registry Experience
  Garth Healey, Australian Bone Marrow Donor Registry, Australia

AustraliaPlenary Session 4: HLA Genomics and Clinical Relevance

• HLA in Diseases Susceptibility and Personalized Medicine Prof.Katsushi Tokunaga, Director, Genome Medical Science Project, Research Institute, National Center for Global Health and Medicine (NCGM); Director, Central Biobank, National Center Biobank Network (NCBN), Japan

• Clinical implementation of HLA long-read sequencing
  Assoc. Prof.Pajaree Chariyavilaskul, Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Thailand

• HLA Typing and Beyond with Nanopore Sequencing
  Dr.Thidathip Wongsurawat, Head Division of Medical Bioinformatics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

• Beyond Traditional HLA Typing: NGS and HLA Imputation for Comprehensive Analysis of HLA Alleles in Thai SLE Patients
  Dr.Charles Khor Seik-Soon, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore

🌏 Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) Annual Scientific Meeting 2025 (5–7 February 2025)

Friday February 7th, 2025 (Day 3)
Plenary Session 5: Solid Organ Transplantation I

• Implementation of Virtual Crossmatching in Australia: the laboratory experience
  Fiona Hudson, Senior Scientist at VTIS, Melbourne, Australia

• Determining compatibility in Solid Organ Transplantation –Challenges and Opportunities
  Rhonda Holdsworth HLA Specialist and Clinical Scientist Specialist Advisor, Transplantation andImmunogenetics Services, Pathology and Clinical Governance Division, Australian Red Cross Lifeblood, Australia

• Non-HLA antibodies in solid organ transplant
  Dr Lucy Sullivan, Scientific Director at Australian Red Cross LifeBlood, Australia

Special Lecture by the ASHI President

• Expanding Access to Transplantation: Utilization of A2 Kidneys for O and B Recipients
  Dr. Cathi Murphey, Director, Histocompatibility and Immunogenetics Laboratory, Southwest Immunodiagnostics, Inc.. San Antonio, USA

Session 6: Solid Organ Transplantation II

• Management of Highly sensitized kidney transplant recipients
  Professor Jaeseok Yang, Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital; Laboratory of Transplantation Immunology, Yonsei University Severance Hospital, Korea

• Management of Highly sensitized kidney transplant recipients
  Professor Yingyos Avihingsanon, Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Thailand

🌏 Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) Annual Scientific Meeting 2025 (5–7 February 2025)

คลิกที่นี่ to view highlights and the atmosphere from previous conferences.